Prostatic Obstruction Investigation Team Multicenter Study
NCT03394651 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 11500
Last updated 2018-11-14
Summary
The present is a multicenter, observational study organized by the Prostatic Obstruction Investigation Team (POInT), with a main purpose of looking into the current status and symptom progression of male lower urinary tract symptoms patients in China.
Conditions
- Lower Urinary Tract Symptoms
Interventions
- DRUG
-
Oral medications to treat lower urinary tract symptoms
Patients in this group will receive oral medication(s) depending on doctors' prescriptions.
- PROCEDURE
-
Minimal invasive transurethral prostate procedures
Patients in this group will receive surgical treatment.
Sponsors & Collaborators
-
Beijing Hospital
collaborator OTHER_GOV -
Zhongda Hospital
collaborator OTHER -
RenJi Hospital
collaborator OTHER -
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
collaborator OTHER -
The Second Hospital of Nanjing Medical University
collaborator OTHER -
Shanghai Changzheng Hospital
collaborator OTHER -
Third Affiliated Hospital, Sun Yat-Sen University
collaborator OTHER -
First Affiliated Hospital of Suzhou Medical College
collaborator OTHER -
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
collaborator OTHER -
Zhujiang Hospital
collaborator OTHER -
Zhejiang University
collaborator OTHER -
Shanghai Zhongshan Hospital
collaborator OTHER -
Xinqiao Hospital of Chongqing
collaborator OTHER -
Zhejiang Provincial People's Hospital
collaborator OTHER -
Huashan Hospital
collaborator OTHER -
Southwest Hospital, China
collaborator OTHER -
First Affiliated Hospital of Fujian Medical University
collaborator OTHER -
The First Affiliated Hospital of Beijing University
collaborator UNKNOWN -
Daping Hospital and the Research Institute of Surgery of the Third Military Medical University
collaborator OTHER -
Tianjin Medical University Second Hospital
collaborator OTHER -
The Third Affiliated Hospital of Beijing University
collaborator UNKNOWN -
Jiangsu Provincial People's Hospital
collaborator OTHER -
Changhai Hospital
lead OTHER
Principal Investigators
-
Yinghao Sun, MD, PhD · Changhai Hospital
-
Wei Xue, MD, PhD · RenJi Hospital
-
Qi-Xiang Song, MD,PhD · Changhai Hospital
Eligibility
- Min Age
- 45 Years
- Sex
- MALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2018-04-01
- Primary Completion
- 2019-04-01
- Completion
- 2022-04-01
Countries
- China
Study Locations
More Related Trials
-
A-botulinic Toxin for Symptomatic Benign Prostate Hypertrophy
NCT01275521 ·Status: COMPLETED ·Phase: PHASE3
-
Effect of Enhanced External Counterpulsation on Lower Urinary Tract Symptoms
NCT01815697 ·Status: UNKNOWN ·Phase: NA
-
Risk Factors for Chronic Prostatitis Patients in Northwest China
NCT06385977 ·Status: RECRUITING
-
Multi-center Clinical Observation of a New Treatment Method Based on the Pathogenesis of Obstructive Prostatitis
NCT04128280 ·Status: UNKNOWN ·Phase: NA
-
(Phosphodiesterase 5 Inhibitors & α-blockers): Single Versus Combined Therapy in Benign Prostatic Hyperplasia
NCT05236634 ·Status: UNKNOWN ·Phase: NA
-
Prostatic Artery Embolization for Benign Prostatic Obstruction
NCT03099421 ·Status: COMPLETED ·Phase: NA
-
Investigating Medication vs. Prostatic Urethral Lift: Assessment and Comparison of Therapies for BPH
NCT04987892 ·Status: RECRUITING ·Phase: PHASE4
-
Prostate Artery Embolization for the Treatment of Symptomatic Benign Prostatic Hyperplasia
NCT03055624 ·Status: COMPLETED ·Phase: NA
-
Prostatic Artery Embolization vs. Pharmacotherapy for LUTS/BPH
NCT04245566 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3
-
Real World Data on Management of Male LUTS
NCT03075449 ·Status: COMPLETED
-
Prostate Artery Embolization (PAE) for Treatment of Benign Prostatic Hyperplasia
NCT02592473 ·Status: UNKNOWN ·Phase: NA
-
Clinical Trial of Prostatic Arterial Embolization Versus a Sham Procedure to Treat Benign Prostatic Hyperplasia
NCT02074644 ·Status: COMPLETED ·Phase: NA
-
Prostate Enucleation With Intravesical Botox Injections in Treating BPH and Bladder Overactivity
NCT05910983 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
The Association of Baseline Characteristics of Male Patients Presented With LUTS and Long Term Clinical Outcomes
NCT04764903 ·Status: COMPLETED
-
Benigh Prosatic Hyperplasia/Lower Urinary Tract Symptoms
NCT05288621 ·Status: UNKNOWN ·Phase: NA
-
Prostatic Artery Embolization Versus Medical Treatment in Symptomatic Benign Prostatic Hyperplasia
NCT02869971 ·Status: COMPLETED ·Phase: PHASE3
-
Antimuscarinics as the First-line Treatment for Male With IPSS-V/S≤1
NCT01661621 ·Status: COMPLETED ·Phase: PHASE4
-
Prophylactic Alpha-blockers in the Prevention of Urinary Retention Post Inguinal Hernia Repair
NCT03314259 ·Status: UNKNOWN ·Phase: EARLY_PHASE1
-
Safety and Efficacy of OCL 503 in Prostate Artery Embolization
NCT02509975 ·Status: COMPLETED ·Phase: NA
-
Enhanced Clinical Decisions for Management of Benign Prostatic Hyperplasia Using Patient-Reported Outcomes
NCT05898932 ·Status: RECRUITING
-
Intraprostatic Botulinum Toxin Type "A" Injection in Patients With Benign Prostatic Hyperplasia and Unsatisfactory Response to Medical Therapy
NCT01566292 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Efficacy of Prostatic Artery Embolization (PAE) in Patients With Severe Benign Prostatic Hyperplasia (BPH)
NCT02167919 ·Status: COMPLETED ·Phase: NA
-
Comparison of H-FIRE and TURP in Treating Benign Prostatic Hyperplasia
NCT05306145 ·Status: COMPLETED ·Phase: NA
-
The Predictive Value of Prostate Spherical Volume Ratio in Lower Urinary Tract Symptoms and Clinical Progression of Benign Prostatic Hyperplasia:A Single-center Paired Validating Confirmatory Study
NCT06448533 ·Status: COMPLETED
-
Prostatic Artery Embolization (PAE) for Treatment of Signs and Symptoms of Benign Prostatic Hyperplasia (BPH) Using Bead Block Microspheres
NCT03052049 ·Status: COMPLETED ·Phase: NA